Acesion Pharma Starts AP31969 Phase 2 Trial in Atrial
06 Jan 2026 //
PR NEWSWIRE
Acesion announces Nature Medicine publication of results in Atrial Fibrillation
13 Dec 2023 //
PR NEWSWIRE
Acesion Pharma Closes Oversubscribed €45M Series B Financing Round
26 Sep 2023 //
PR NEWSWIRE
Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
15 May 2023 //
PR NEWSWIRE
Acesion Pharma reports positive preclinical data for AF therapy
15 May 2023 //
CLINICAL TRIALS ARENA

Market Place
Sourcing Support